U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07652294) titled 'Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD' on June 11.
Brief Summary: This is a multicenter, long-term extension (LTE) study in participants with ulcerative colitis (UC) from Study SPY123-201 (The SKYLINE-UC study).
Study Start Date: June 08
Study Type: INTERVENTIONAL
Condition:
Ulcerative Colitis
Inflammatory Bowel Diseases
Colitis
Colitis, Ulcerative
Intervention:
DRUG: SPY001
Experimental
DRUG: SPY002
Experimental
DRUG: SPY003
Experimental
Recruitment Status: ENROLLING_BY_INVITATION
Sponsor: Spyre Therapeutics, Inc.
Published by HT Digital Content Services wit...